We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Time will tell but I have observed this company for a while now and I guarantee that the upside potential for this is tremendous. The diagnostics market is poised to expand considerably over the coming years and with the diverse application of ONCimmune's service, I think deals will be closed. Many deals.
I also believe that the (Bio-) Pharma industry is awake and on the up again. Coming out of a prolonged period of under investment and bearish sentiment, there is a lot more activity on the M&A market. I can see a bull charging from the distance
Probably right. Someone certainly thinks there is reason to buy.
I bought a modest amount of shares at 21p. It was mainly based upon a sudden 12% jump and the RNS about meeting thresholds and declaring interest. There seemed to be few but chunky buys. There was zip on this board. I'm no expert at all and probably not a sensible reason to buy, but I have seen one of the board, Goold, mentioned in other articles. They seem like they have their heads screwed on and are serious people.
In the most recent report from Feb 24, it was indicated that H1 FY24 results should be made public via a trade update in May. I assume that the shares will start to get bought up because it is a phenomenal entry price for a business that will have their first 'clean' report post sale of non-core assets. This report will show an expected high increase in revenue and possibly reveal a rich and growing pipeline. At this point the strategy I'd defined, the resources are all hired, the overheads are gone and the margins are wide. On top of that there is a solid baseline revenue from existing contracts incl. Freenome and other MSA and ongoing projects. Many more to come. I believe we are at the 'tipping point' right now.
I hope others agree. Curious to read other opinions. But I cannot see the SP going back down from here, quite the opposite
Something is going on here. Anyone know if a trading update is expected?
AIM moves in mysterious ways.
Sure these stocks will start getting gobbled up with the Mai FY24 H1 results. If we can see a strong growth trajectory
Falling even with buys...
Someone clearing out their big holding (for whatever reasons) or the usual AIM circus??
Great value though, will consider buying more!
I wish i had some spare change right now... ONC taking a big hit knocking off 20%. At these levels a definete buy to get the average down.
Like you said Dr. This is a long game but i firmly believe that the latest report will have been the worst summing up a year of change and metamorphosis.
I think right now is when the cocoon cracks...
Theboyg, I think they are doing the right things: setting the company up for sales and growth. It may take time to demonstrate further they are on the right track. Results going forward will show if this is real or just fluff. The tech is really quite special and should be a winner going forward. Good entry point. Very thin trade though, I think most long term holders do just that: hold!
Pardon, ...sale of Oncimmune Limited and Oncimmune Europe GmbH
I have not. I think the company has been in this spot here 2 years ago when the Sales strategy and structure was laid out by former CEO. Company needs to prove that debt to equity ratio is solid and not spiral out of control. I think there should be a check around that given reduced overheads from asset sale.
The other component is proof that there is sustainable and predictable growth in the stock. I hope 150% is the start to a consistent acceleration based on repeat customer contracts MSAs and longer term commitments as from Freenome.
Sad to say it may take another couple of reports for this to recover but based on the fugures (unmuddied by sale of Oncimmune Plc), right now i think is a smashing SP.....if you believe in thw longer term prospects of the business. I do
Anyone attend webinar??
Down since then
I watched video
Unimpressive I thought
Vox Market's Paul Hill interviews Martin Gouldstone CEO ONC
https://youtu.be/YxLVTHyDw3Q?si=08QtPox2ApkYmz_5
1 trade today? Any takers?
Anyone else want to put a penny in the tin?
No? Alright - have a great weekend all.
Its not untypical for an acting CEO to be on the boards of multiple companies. If anything i see this as a positive for Networking/ business opportunity and validation of their quality.
Https://www.lse.co.uk/rns/VAL/proposed-appointment-of-non-executive-director-f12nhzo9af1tobc.html
Hi all. I am reading a highly encouraging report with exciting prospects, growth and marging expansion.
Revenue in FY 2024 expected to be approximately £3m, compared with FY 2023 revenue from continuing operations of £1.2m, a growth rate of 150%. Coming up to the end of H1 FY 2024, work to achieve approximately 75% of the forecast FY 2024 revenue has been secured, with the majority of samples received or expected imminently allowing lab work to begin and revenue to be recognised in due course.
Terribly sorry for the typos. On my phone.
Sorry to hear that mc. You are not the only one with a gaping loss %.... many have already jumped ship and some have not yet cut the cord.
Lots of frustration here with this SP. Freenome doing very well esp since acquisition of non core ONC business. As for ONC now i just could not imagine this business failing to capitalise on their pole position and the largely untapped market. With ONCs margins and new structure leadership and commercial approach etc i would question whether every little thing in this world if this was not the bottom of where this SP sits.
Years ago they made 170k revenue and shares traded at close to 1GBP.
This could have been due to low i terest rates and the pote tially great growth prospects. I expect strong growth guidance from leadership and over time i terest rates will go down too. OnC is already making tons more revenue than 170k.
To all here. Am I naive in wanting to hold for another fiscal at the minimun to seethe pendulum finally swing the other way?
Well, I finally bailed on Monday after sitting on a 90% loss for far too long. Knowing my luck, you guys are in for a treat soon, lol!
I see this stock being traded down coincidentally in line with wider market movements.
#PCE reading
# GDP data
Is there another reason we are seeing 9%drop today. Or are we just bracing for the number we are about to be exposed to for FY23.
Wait and see. The commercial update from Martin end of November sounded very promising.
It is no doubt going to be fairly bad, but I am only looking forward at this point!!
I feel the past is already baked into the current price and based on the recent strategic re-set, things are going to work out!
Some further good news would be nice also!
Annual report should be released any day now